Group 1 - Neuralink Corp., led by Elon Musk, plans to launch its first clinical trial in the Middle East [1] - The trial will focus on how individuals with movement and speech disorders can use thought to control devices and communicate [1] - The company will collaborate with the Abu Dhabi Department of Health and conduct the trial at the Cleveland Clinic Abu Dhabi [1] Group 2 - Neuralink has already implanted the device in three patients and is seeking more patients globally to expand the trial [1]